Pregled bibliografske jedinice broj: 1233047
SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH A DIFFERENT DONOR: IMPLICATIONS FOR CHIMERISM ANALYSIS
SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH A DIFFERENT DONOR: IMPLICATIONS FOR CHIMERISM ANALYSIS // Book of Abstracts
Pula, Hrvatska, 2022. str. 121-121 (predavanje, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 1233047 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
SECOND HEMATOPOIETIC STEM CELL TRANSPLANTATION
WITH A DIFFERENT DONOR: IMPLICATIONS FOR CHIMERISM
ANALYSIS
Autori
Štingl Janković, Katarina ; Maskalan, Marija ; Burek Kamenarić, Marija ; Serventi-Seiwerth, Ranka ; Duraković, Nadira ; Vrhovac, Radovan ; Žunec, Renata ; Grubić, Zorana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts
/ - , 2022, 121-121
Skup
14. Hrvatski biološki kongres
Mjesto i datum
Pula, Hrvatska, 12.10.2022. - 16.10.2022
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Domaća recenzija
Ključne riječi
hematopoietic stem cell transplantation ; chimerism
Sažetak
Chimerism analysis provides valuable information about the efficacy of the hematopoietic stem cell (HSC) transplantation as treatment for various hematologic diseases and disorders. The method of choice for this analysis has recently shifted form short tandem repeat (STR) loci detection towards real-time PCR based methods due to their higher sensitivity. The present study was undertaken in order to evaluate whether the STR analysis should remain a preferred choice in cases when a patient receives a second HSC transplant from a different donor. The study included 17 patients for whom the first transplantation did not achieve favourable outcome, so a second transplantation, with a different donor, was performed. Samples of patient before HSCT, both donors and patient after second HSCT were amplified for 21 STR markers using a commercial kit (Aneufast™ QF-PCR Kit, Genomed Biotech, Harrow, UK). Only the second donor was present in 16 cases, while in the remaining one case, both the first and the second donor were detected in a 36% vs. 64% ratio in the post HSCT sample. This case supports the use of STR markers in chimerism evaluation in all cases when there is a possibility that more than two distinct genotypes are present in tested sample as is the case with second HSCT. As opposed to biallelic insertion/deletion polymorphisms analysed in real- time PCR based protocols, STR markers provide sufficient polymorphism to reliably distinguish all genotypes present in post HSCT sample.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Zorana Grubić
(autor)
Renata Žunec
(autor)
Ranka Serventi-Seiwerth
(autor)
Marija Maskalan
(autor)
Katarina Štingl Janković
(autor)
Nadira Duraković
(autor)
Radovan Vrhovac
(autor)
Marija Burek Kamenarić
(autor)